Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

US Patent 11945853 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound as highly selective ROS1 inhibitor and use thereof2025
Delivery of card protein as therapy for occular inflammation2025
Manufacturing process and apparatus for duckbill mask2025
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2024
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2024
Delivery of NRF2 as therapy for protection against reactive oxygen species2024
Delivery of card protein as therapy for ocular inflammation2023
Small angiotensin peptide expression system in mammalian cells2022
Genetically modified probiotics for oral delivery of renin-angiotensin related t2022
Genetically modified probiotics for oral delivery of renin-angiotensin related t2022
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2022
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bio2022